Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

about

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

Item

http://www.wikidata.org/entity/Q51281757

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@en

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@nl

type

Item

label

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@en

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@nl

prefLabel

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@en

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@nl

P1476

Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.

@en

P2093

Baohua Huang

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Meiling Tian

http://www.w3.org/2001/XMLSchema#string

Qingle Lu

http://www.w3.org/2001/XMLSchema#string

Yuqin Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1

Fibulins: physiological and disease perspectives.

Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence

Fibulin-1 and fibrinogen in human atherosclerotic lesions.

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.

Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes.

Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.

Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice.

Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes.

P304

1209-1212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JIM-2016-000130

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27422995

http://www.w3.org/2001/XMLSchema#string